ArticleCureus2026
Changes in Maternal Leucine-Rich α-2 Glycoprotein Levels During Pregnancy: Comparison Between Preterm and Term Births.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe goal of this study was to longitudinally assess the maternal serum leucine-rich α-2 glycoprotein (LRG) level throughout pregnancy and the puerperium, and to explore its association with preterm birth (PTB).
methodsA total of 37 pregnant women (17 with PTBs and 20 term births as controls) were enrolled in the retrospective study. Serum LRG levels were measured using an enzyme-linked immunosorbent assay at four time points: early, middle, and late pregnancy and puerperium. Placental histopathological examination was performed in selected cases to assess the presence of chorioamnionitis (CAM).
resultsNo significant differences in serum LRG levels were observed between the PTB and control groups during pregnancy, and LRG levels remained stable from early to middle pregnancy (p=0.55). In both groups, LRG levels increased significantly during puerperium compared with the corresponding values during pregnancy (p<0.001). Postpartum LRG levels were numerically higher in the PTB group than in the control group (192.5 ± 49.6 μg/mL vs. 163.9 ± 39.1 μg/mL), although the difference was not statistically significant (p=0.057). Among CAM-positive cases, LRG levels tended to be higher in the PTB group than in the controls (266.4 ± 12.8 μg/mL vs. 161.7 μg/mL; p=0.09).
conclusionsMaternal LRG levels remained stable during pregnancy but increased postpartum, potentially reflecting peripartum inflammation. Maternal serum LRG levels did not differ significantly between preterm and term births. Further studies are required to clarify the significance of puerperal LRG levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.